Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Paraplegia clinical trials

4 of 9 indexed Paraplegia trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Paraplegia: 9 US clinical trials tracked, 4 recruiting.

Paraplegia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is University of Pittsburgh, running 2 of these trials.

Enrollment posture brief

Registry condition paraplegia

OPEN 4 | RECR 44% | LATE 0 | EARLY 0 | RANK #1916 | SPON 2

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Paraplegia (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Paraplegia

Paraplegia lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Paraplegia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Paraplegia is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Paraplegia research.

    University of Pittsburgh accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Paraplegia trials plan to enrol fewer than 100 people.

    Median target enrolment is 26 among the 9 trials that report a genuine target (sentinel values excluded). 7 of those (77.8%) plan for fewer than 100 participants.

  4. Paraplegia research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Paraplegia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

powered exoskeleton Device
1 trials
Functional Electrical Stimulation Leg Cycle Ergometry Device
1 trials
Transcutaneous electrical spinal stimulation Device
1 trials
Percutaneous epidural electrical spinal stimulation Device
1 trials
Intervention B: Education on wheelchair provision Other
1 trials
Part 2 of intervention A - Asynchronous feedback from a remote trainer Other
1 trials
Part 1 of intervention A - Wheelchair skills training modules Other
1 trials
Extracorporeal Shockwave Therapy Device
1 trials

US sites by state

Facility locations filed on Paraplegia trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Ohio 2 trials
Minnesota 2 trials
Texas 1 trials
New York 1 trials
New Jersey 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Paraplegia page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Paraplegia condition card totals 9 registered trials; most-linked intervention powered exoskeleton; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.